Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study

Medicine & Life Sciences

• efavirenz 100%
• etonogestrel 90%
• Contraceptive Agents 88%
• Ethinyl Estradiol 71%
• Atazanavir Sulfate 69%
• Pharmacokinetics 63%
• Hormones 59%
• Ritonavir 35%
• Nonparametric Statistics 26%
• Control Groups 25%
• Acquired Immunodeficiency Syndrome 15%
• National Institute of Allergy and Infectious Diseases (U.S.) 14%
• National Institute of Child Health and Human Development (U.S.) 13%
• Therapeutics 13%
• Product Labeling 13%
• National Institute of Mental Health (U.S.) 12%
• HIV 12%
• Clinical Trials 12%
• South America 11%
• Ovariectomy 10%
• Africa South of the Sahara 10%
• Ovulation 10%
• Group Psychotherapy 9%
• National Institutes of Health (U.S.) 9%
• CD4 Lymphocyte Count 9%
• Drug Interactions 9%
• HIV-1 8%
• RNA 6%
• Pediatrics 6%
• Mothers 5%